Related Party Transactions (Details)
|
|
1 Months Ended |
12 Months Ended |
|
|
Apr. 26, 2016
$ / shares
shares
|
Aug. 31, 2021
ft²
|
Feb. 28, 2021
USD ($)
$ / shares
shares
|
Mar. 31, 2018
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
|
Oct. 31, 2020 |
| Public Offerings |
|
|
|
|
|
|
| Proceeds from sale of stock |
|
|
|
|
$ 31,989,000
|
|
| Owners of More Than 5% of Our Common Stock or Board of Directors |
|
|
|
|
|
|
| Area of property subleased | ft² |
|
7,585
|
|
|
|
|
| Sublease income - related party |
|
|
|
|
235,000
|
|
| Angel Pharmaceuticals |
|
|
|
|
|
|
| Owners of More Than 5% of Our Common Stock or Board of Directors |
|
|
|
|
|
|
| Internal personnel costs |
|
|
|
|
200,000
|
|
| Third-party costs |
|
|
|
|
1,600,000
|
|
| Third-party costs expensed in prior years |
|
|
|
|
600,000
|
|
| Third-party costs expensed in current years |
|
|
|
|
1,000,000.0
|
|
| ICON plc |
|
|
|
|
|
|
| Owners of More Than 5% of Our Common Stock or Board of Directors |
|
|
|
|
|
|
| Clinical trial expense |
|
|
|
|
$ 246,000,000,000
|
|
| Follow On Public Offering |
|
|
|
|
|
|
| Public Offerings |
|
|
|
|
|
|
| Issuance of common stock (in shares) | shares |
|
|
9,783,660
|
8,117,647
|
|
|
| Share offering price | $ / shares |
|
|
$ 3.50
|
$ 8.50
|
|
|
| Proceeds from sale of stock |
|
|
$ 32,000,000.0
|
$ 64,900,000
|
|
|
| Follow On Public Offering | Orbimed Advisors LLC |
|
|
|
|
|
|
| Public Offerings |
|
|
|
|
|
|
| Issuance of common stock (in shares) | shares |
|
|
|
1,285,714
|
|
|
| Owners of More Than 5% of Our Common Stock or Board of Directors |
|
|
|
|
|
|
| Aggregate Purchase Price |
|
|
|
$ 4,499,999
|
|
|
| Follow On Public Offering | Richard A. Miller, M.D. |
|
|
|
|
|
|
| Public Offerings |
|
|
|
|
|
|
| Issuance of common stock (in shares) | shares |
|
|
|
100,000
|
|
|
| Owners of More Than 5% of Our Common Stock or Board of Directors |
|
|
|
|
|
|
| Aggregate Purchase Price |
|
|
|
$ 350,000
|
|
|
| Over-Allotment Option |
|
|
|
|
|
|
| Public Offerings |
|
|
|
|
|
|
| Issuance of common stock (in shares) | shares |
502,618
|
|
1,212,231
|
1,058,823
|
|
|
| Share offering price | $ / shares |
$ 15.00
|
|
|
|
|
|
| Angel Pharmaceuticals Co. Ltd |
|
|
|
|
|
|
| Related Party Transactions |
|
|
|
|
|
|
| Ownership interest (as percent) |
|
|
|
|
49.70%
|
53.20%
|